Bristol Myers Squibb reached a $239 million settlement of claims that former Celgene shareholders were defrauded about prospects for the psoriasis drug Otezla, and multiple sclerosis treatment now known as Zeposia. A preliminary settlement of the 7-1/2-year-old class action was …
White House Weighs US Incubator for Cyber Research, Startups
The Trump administration is weighing a plan to establish a government-led incubator aimed at investing in cybersecurity research and spinning out startups focused on developing
